NLRP3 and non-small cell lung carcinoma: The mechanism may be related to the simvastatin-induced activation of the NLRP3 inflammatory body, caspase-1, IL-1β and interleukin-18 (IL-18), thereby inducing pyroapoptosis in NSCLC.